Search For "baricitinib"
WHO recommends two new drugs to treat patients with COVID-19
Updated : 4 years, 4 months ago IST
Geneva [Switzerland], January 14 (ANI): The World Health Organization (WHO) Guideline Development Group recommended the use of two arthritis drugs called baricitinib and interleukin-6 (IL-6) in combination with corticosteroids to treat patients with severe or critical COVID-19, on Friday.
Read More
Lilly India gets nod for use of monoclonal antibody drugs for treating Cov
Updated : 5 years ago IST
New Delhi [India], June 1 (ANI): Eli Lilly and Company India said on Tuesday it has received permission for restricted emergency use of its antibody drugs bamlanivimab 700 mg and etesevimab 1,400 mg in India for treatment of patients with mild to moderate coronavirus disease 2019 (Covid-19).
Read More
Lilly signs pact with Natco to accelerate availability of baricitinib for
Updated : 5 years ago IST
New Delhi [India], May 17 (ANI): Eli Lilly and Company said on Monday it has issued an additional royalty-free, non-exclusive voluntary license to Natco Pharma, a local pharmaceutical manufacturer of generic medicines.
Read More
Goa includes Baricitinib medicine to COVID-19 treatment protocol: Health m
Updated : 5 years ago IST
Panaji (Goa) [India], May 16 (ANI): The Goa Health Department is working on additional treatment protocols with the introduction of Baricitinib medicine for COVID-19 patients, informed Goa health minister Vishwajit P Rane on Saturday.
Read More
Lilly signs 3 more pacts to accelerate availability of baricitinib for Cov
Updated : 5 years ago IST
New Delhi [India], May 13 (ANI): Eli Lilly and Company said on Thursday it has issued additional royalty-free, non-exclusive voluntary licenses to Dr Reddy's Ltd, MSN Laboratories and Torrent Pharmaceuticals who will collaborate to accelerate and expand the availability of baricitinib in Ind
Read More
Dr Reddy's enters into licensing agreement with Eli Lilly for COVID-19 tre
Updated : 5 years ago IST
Hyderabad (Telangana) [India], May 12 (ANI): Dr Reddy's Laboratories on Tuesday said that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialization of the drug baricitinib, in India.
Read More
Lilly signs pacts with Cipla, Lupin, Sun Pharma to accelerate availability
Updated : 5 years ago IST
New Delhi [India], May 10 (ANI): US pharmaceutical major Eli Lilly said on Monday it has issued royalty-free, non-exclusive voluntary licenses to Cipla, Lupin and Sun Pharmaceutical to accelerate and expand the availability of baricitinib in India for Covid-19 patients.
Read More